as on October 24, 2025 at 1:29 am IST
Day's Low
Day's High
23.48%
Downside
10.87%
Upside
52 Week's Low
52 Week's High
73.43%
Downside
512.61%
Upside
Check Neumora Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$291.5M
EPS (TTM)
-1.4162
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-264.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-89.37%
Compare market cap, revenue, PE, and other key metrics of Neumora Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $291.5M | NA | NA | 0.00% | |
BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
NA | $35.3B | NA | NA | -3.89% | |
BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
BUY | $61.3B | 0.85% | 14.6 | 31.37% |
The Neumora Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neumora Therapeutics, Inc. investment value today
Current value as on today
₹21,933
Returns
Returns from Neumora Therapeutics, Inc. Stock
Dollar Returns*
₹4,653 (+4.65%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Neumora Therapeutics, Inc.. Average target price of $7
Get share price movements and forecasts by analysts on Neumora Therapeutics, Inc..
What analysts predicted
67.14%UPSIDE
Target Price
$7
Current Price
$2.3
Analyzed by
12 Analysts
Target
$7.00
Neumora Therapeutics, Inc. target price $7, a slight upside of 67.14% compared to current price of $2.3. According to 12 analysts rating.
Search interest for Neumora Therapeutics, Inc. Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:24% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, NMRA stock has moved up by 140.5%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 144.9%
Organisation | Neumora Therapeutics, Inc. |
Headquarters | 490 Arsenal Way, Watertown, MA, United States, 02472 |
CEO | Dr. Daljit Singh Aurora Pharm.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Daljit Singh Aurora Pharm.D. | Chief Operationg & Development officer |
Ms. Carol Suh | Co-Founder & Chief Strategy Officer |
Mr. Michael Lee Milligan | CFO & Principal Accounting Officer |
Dr. Nicholas Brandon Ph.D. | Chief Scientific Officer |
Helen Rubinstein | Head of Investor Relations |
Ms. Amy Sullivan | Chief Human Resources Officer |
Ms. Lori Houle | Chief Technical Operations & Quality Officer |
Mr. Pablo Gersberg | Chief Information Officer |
Mr. Jason G. Duncan J.D. | Chief Legal & Administrative Officer |
Neumora Therapeutics, Inc. share price today is $2.3 as on at the close of the market. Neumora Therapeutics, Inc. share today touched a day high of $2.55 and a low of $1.76.
Neumora Therapeutics, Inc. share touched a 52 week high of $14.09 on and a 52 week low of $0.61 on . Neumora Therapeutics, Inc. stock price today i.e. is closed at $2.3,which is 83.68% down from its 52 week high and 276.43% up from its 52 week low.
Neumora Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Neumora Therapeutics, Inc. (NMRA) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Neumora Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neumora Therapeutics, Inc. share’s latest price of $2.3 as on October 24, 2025 at 1:29 am IST, you will get 4.3478 shares of Neumora Therapeutics, Inc.. Learn more about
fractional shares .